Vertex cystic fibrosis drug combination shows strong results in pivotal clinical trials

Vertex Pharmaceuticals said Tuesday that treatment with a combination of three cystic fibrosis drugs resulted in a statistically significant improvement in lung function for patients enrolled in two pivotal clinical trials.